Global Study Comparing a rivAroxaban-based Antithrombotic Strategy to an antipLatelet-based Strategy After Transcatheter aortIc vaLve rEplacement to Optimize Clinical Outcomes
Clinical trial NCT02556203 · TERMINATED
Trial details
- NCT number
- NCT02556203
- Sponsor
- Bayer
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-16
- Primary completion
- 2018-11-27
- Enrollment
- 1653
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.